Headlands Technologies LLC raised its holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 31.3% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,037 shares of the biopharmaceutical company’s stock after acquiring an additional 2,153 shares during the quarter. Headlands Technologies LLC’s holdings […]
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Analysts at Leerink Partnrs issued their Q3 2024 earnings per share (EPS) estimates for shares of Agios Pharmaceuticals in a research report issued to clients and investors on Monday, February 5th. Leerink Partnrs analyst A. Berens expects that the biopharmaceutical company will post earnings per share of […]
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Analysts at Zacks Research raised their FY2024 EPS estimates for Agios Pharmaceuticals in a note issued to investors on Thursday, January 25th. Zacks Research analyst A. Chakraborty now anticipates that the biopharmaceutical company will post earnings of ($6.05) per share for the year, up from their previous […]
Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) were up 5.2% on Thursday . The company traded as high as $23.24 and last traded at $22.62. Approximately 365,022 shares changed hands during mid-day trading, a decline of 62% from the average daily volume of 962,941 shares. The stock had previously closed at $21.51. […]
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) Director Jacqualyn A. Fouse sold 10,722 shares of the company’s stock in a transaction that occurred on Wednesday, January 24th. The shares were sold at an average price of $21.64, for a total value of $232,024.08. Following the transaction, the director now owns 129,253 shares of the […]